Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy.
Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Grossberg AJ, et al. Among authors: heukelom j. Sci Data. 2018 Sep 4;5:180173. doi: 10.1038/sdata.2018.173. Sci Data. 2018. PMID: 30179230 Free PMC article.
Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, Frank S, Phan J, Beadle B, Skinner HD, Morrison WH, Rosenthal DI. Grossberg AJ, et al. Among authors: heukelom j. JAMA Oncol. 2016 Jun 1;2(6):782-9. doi: 10.1001/jamaoncol.2015.6339. JAMA Oncol. 2016. PMID: 26891703 Free PMC article.
Quantitative body mass characterization before and after head and neck cancer radiotherapy: A challenge of height-weight formulae using computed tomography measurement.
Chamchod S, Fuller CD, Mohamed AS, Grossberg A, Messer JA, Heukelom J, Gunn GB, Kantor ME, Eichelberger H, Garden AS, Rosenthal DI. Chamchod S, et al. Among authors: heukelom j. Oral Oncol. 2016 Oct;61:62-9. doi: 10.1016/j.oraloncology.2016.08.012. Epub 2016 Aug 31. Oral Oncol. 2016. PMID: 27688106 Free PMC article.
Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy.
Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Grossberg AJ, et al. Among authors: heukelom j. Sci Data. 2018 Nov 27;5(1):1. doi: 10.1038/s41597-018-0002-5. Sci Data. 2018. PMID: 30482902 Free PMC article.
Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.
Heukelom J, Kantor ME, Mohamed ASR, Elhalawani H, Kocak-Uzel E, Lin T, Yang J, Aristophanous M, Rasch CR, Fuller CD, Sonke JJ. Heukelom J, et al. Radiother Oncol. 2020 Jan;142:100-106. doi: 10.1016/j.radonc.2019.07.034. Epub 2019 Aug 17. Radiother Oncol. 2020. PMID: 31431381 Free PMC article.
Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer.
McCulloch MM, Lee C, Rosen BS, Kamp JD, Lockhart CM, Lee JY, Polan DF, Hawkins PG, Anderson CJR, Heukelom J, Sonke JJ, Fuller CD, Balter JM, Ten Haken RK, Eisbruch A, Brock KK. McCulloch MM, et al. Among authors: heukelom j. Pract Radiat Oncol. 2019 Jul-Aug;9(4):e422-e431. doi: 10.1016/j.prro.2019.02.014. Epub 2019 Mar 2. Pract Radiat Oncol. 2019. PMID: 30836190 Free PMC article.
MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers.
Mulder SL, Heukelom J, McDonald BA, Van Dijk L, Wahid KA, Sanders K, Salzillo TC, Hemmati M, Schaefer A, Fuller CD. Mulder SL, et al. Among authors: heukelom j. Cancers (Basel). 2022 Apr 10;14(8):1909. doi: 10.3390/cancers14081909. Cancers (Basel). 2022. PMID: 35454816 Free PMC article. Review.
Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer.
Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C. Heukelom J, et al. BMC Cancer. 2013 Feb 22;13:84. doi: 10.1186/1471-2407-13-84. BMC Cancer. 2013. PMID: 23433435 Free PMC article. Clinical Trial.
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach.
Even AJ, Hamming-Vrieze O, van Elmpt W, Winnepenninckx VJ, Heukelom J, Tesselaar ME, Vogel WV, Hoeben A, Zegers CM, Vugts DJ, van Dongen GA, Bartelink H, Mottaghy FM, Hoebers F, Lambin P. Even AJ, et al. Among authors: heukelom j. Oncotarget. 2017 Jan 17;8(3):3870-3880. doi: 10.18632/oncotarget.13910. Oncotarget. 2017. PMID: 27965472 Free PMC article.
57 results